Citadel Advisors - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$9,728,402
-31.8%
944,505
+9.2%
0.00%
-33.3%
Q2 2023$14,256,765
+121.6%
865,095
+23.2%
0.00%
+50.0%
Q1 2023$6,432,894
-19.6%
702,281
-37.1%
0.00%
+100.0%
Q4 2022$7,997,699
+51.5%
1,116,997
+6.0%
0.00%0.0%
Q3 2022$5,278,000
+100.5%
1,053,520
-2.4%
0.00%
Q2 2022$2,633,000
-19.2%
1,078,962
+126.3%
0.00%
Q1 2022$3,257,000
-2.8%
476,797
+15.0%
0.00%
Q4 2021$3,350,000
+37.5%
414,576
+66.8%
0.00%
Q3 2021$2,436,000
+48.0%
248,587
+1.7%
0.00%
Q2 2021$1,646,000
-28.5%
244,509
-4.0%
0.00%
Q1 2021$2,302,000
+89.5%
254,667
+40.1%
0.00%
Q4 2020$1,215,000
-3.0%
181,811
-26.8%
0.00%
Q3 2020$1,252,000
+1.5%
248,420
+62.7%
0.00%
Q2 2020$1,234,000
-22.5%
152,673
-23.8%
0.00%
-100.0%
Q1 2020$1,592,000
-3.4%
200,414
-8.2%
0.00%
Q4 2019$1,648,000
+663.0%
218,258
+318.6%
0.00%
Q3 2019$216,000
+39.4%
52,136
-3.3%
0.00%
Q2 2019$155,000
-38.0%
53,903
-44.4%
0.00%
Q4 2018$250,000
-64.3%
96,885
-39.3%
0.00%
Q3 2018$701,000
-60.6%
159,540
-45.0%
0.00%
-100.0%
Q2 2018$1,777,000
+43.5%
289,891
+70.7%
0.00%
Q1 2018$1,238,000
-8.5%
169,851
+2.9%
0.00%
-100.0%
Q4 2017$1,353,000
+20.9%
165,075
+54.9%
0.00%0.0%
Q3 2017$1,119,000
+216.1%
106,569
+232.2%
0.00%
Q2 2017$354,00032,0800.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders